Insurance holding company Kemper (NYSE: KMPR) will be reporting results this Wednesday after market close. Here’s what you need to know.
Kemper missed analysts’ revenue expectations last quarter, reporting revenues of $1.14 billion, down 4.3% year on year. It was a disappointing quarter for the company, with a significant miss of analysts’ revenue estimates and a significant miss of analysts’ net premiums earned estimates.
Is Kemper a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Kemper’s revenue to decline 1.5% year on year, a reversal from the 5% increase it recorded in the same quarter last year.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Kemper has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Kemper’s peers in the multi-line insurance segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Chubb delivered year-on-year revenue growth of 11.9%, beating analysts’ expectations by 4.7%, and Hartford reported revenues up 6.1%, topping estimates by 40%. Chubb traded down 1.2% following the results while Hartford was also down 3.7%.
Read our full analysis of Chubb’s results here and Hartford’s results here.
Investors in the multi-line insurance segment have had steady hands going into earnings, with share prices up 1.9% on average over the last month. Kemper is up 10.2% during the same time and is heading into earnings with an average analyst price target of $54.67 (compared to the current share price of $34.50).
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a $437 billion giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
